FDA - Food and Drug Administration

10/24/2026 | Press release | Distributed by Public on 10/24/2026 13:59

Ultimate Forza (Male Supplement/Tonight We Ride, LLC) Recall reason: Product contains undeclared Sildenafil, Tadalafil, and Dapoxetine

COMPANY ANNOUNCEMENT

Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Presence of Undeclared Sildenafil, Tadalafil, and Dapoxetine

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date: October 24, 2026 FDA Publish Date: October 24, 2026 Product Type: Dietary Supplements Reason for Announcement:
Recall Reason Description
Product contains undeclared Sildenafil, Tadalafil, and Dapoxetine
Company Name: Tonight We Ride, LLC Brand Name:
Brand Name(s)
Ultimate Forza
Product Description:
Product Description
Male Supplement

Company Announcement

October 24, 2026, Tonight We Ride, LLC of Lakeville, Minnesota is voluntarily recalling all lots of Ultimate Forza Male Supplement capsules to the consumer level because it has been found to contain undeclared Sildenafil, Tadalafil, and Dapoxetine.

The presence of Sildenafil, Tadalafil, and Dapoxetine in this product renders them unapproved drugs for which the safety and efficacy have not been established.

Sildenafil and Tadalafil are active ingredients in FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a licensed health care professional. These undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Dapoxetine is an active ingredient not approved by the U.S. FDA and therefore its safety or efficacy has not been established. Chemically, dapoxetine belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs) used to treat depression. Consumption has been shown to increase the risk of suicidal thinking and behavior in children, adolescents, and young adults.

Ultimate Forza products subject to the recall include the Ultimate Forza Multi-Capsule/Box (Item #810208, UPC 868592000002) and the Ultimate Forza Single Pack (Item #810222, UPC 868592000040). These items were distributed through certain independently owned and operated GNC franchise locations in the United States from 2017 to October 1, 2026. The products were not sold through GNC corporate stores.

Ultimate Forza Male Supplement capsules are marketed as male performance dietary supplements. The Multi-Capsule/Box configuration contains ten blue hard-shell capsules, and the Single Pack contains one capsule.

No adverse events or complaints have been reported to date.

The recall was initiated after GNC's third-party product testing identified undeclared sildenafil, tadalafil, and dapoxetine. Sales were stopped, affected products were quarantined at franchise locations, and customers were notified to discontinue use and return remaining product.

Consumers should stop using Ultimate Forza Male Supplement immediately. Consumers may return unopened or partially used product to a GNC store for a full refund. A receipt or the phone number or email address associated with the loyalty account used for the purchase should be provided so the purchase can be verified.

Consumers with questions may contact GNC Customer Service at 1-877-462-4700 or [email protected].

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online: www.fda.gov/medwatch/report.htm
  • Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

Company Contact Information

Consumers: GNC Customer Service 1-877-462-4700 [email protected]

Product Photos

FDA - Food and Drug Administration published this content on October 24, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 24, 2026 at 19:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]